文献速递血栓与止血

在伴有内含子22倒位的人类与犬中未检测到因子VIII,对抑制剂风险假说提出挑战

Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk.
PubMed 文献 · J Thromb Haemost · 2024-09-02

本研究采用经校验的FVIII特异性抗体组合,通过免疫荧光、免疫沉淀、蛋白质印迹和质谱蛋白质组学分析,检测内含子22倒位(Int22Inv)及F8B mRNA是否表达部分FVIII蛋白、非内皮细胞是否表达FVIII。结果显示非血友病犬肝内皮细胞有FVIII,而Int22Inv犬无;人外周血单个核细胞及B、T细胞系均未检出FVIII或FVIIIB,原代非血友病肝窦内皮细胞可检出FVIII抗原与活性。作者认为结果不支持Int22Inv患者通过表达部分FVIII蛋白诱导免疫耐受。

要点

  • 非血友病犬肝切片FVIII定位于内皮细胞,Int22Inv犬未检出。
  • 人外周血单个核细胞、B细胞系、T细胞系均未检出FVIII或FVIIIB。
  • 原代非血友病肝窦内皮细胞可检出FVIII抗原与活性。

核心结论

  • 若FVIII在非内皮细胞表达或Int22Inv患者表达部分FVIII蛋白,其浓度低于这些敏感检测方法的检测下限。
  • 结果不支持Int22Inv患者通过表达部分FVIII蛋白促进免疫耐受。

研究设计与样本

  • 采用经校验的FVIII特异性抗体组合,对细胞和组织中的FVIII进行标记,并进行免疫沉淀后蛋白质印迹和质谱蛋白质组学分析。
  • 检测对象包括非血友病犬与血友病A-Int22Inv犬肝切片、人外周血单个核细胞、B细胞系、T细胞系、由外周血单个核细胞扩增的细胞系及原代非血友病肝窦内皮细胞。

主要发现

  • 免疫荧光染色显示FVIII定位于非血友病犬肝切片的内皮细胞,而血友病A-Int22Inv犬肝切片未检出。
  • 人外周血单个核细胞、B细胞系、T细胞系及由外周血单个核细胞扩增的细胞系中均未检出FVIII或FVIIIB。
  • 原代非血友病肝窦内皮细胞中可检出FVIII抗原和活性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Almost half of severe hemophilia A (HA) cases are caused by an intron 22 inversion (Int22Inv) mutation, which truncates the 26-exon F8 messenger RNA (mRNA) after exon 22. Another F8 transcript, F8B, is initiated from within F8-intron-22. F8B mRNA consists of a short exon spliced to exons 23 to 26 and is expressed in multiple human cell types. It has been hypothesized that Int22Inv patients have self-tolerance to partial factor (F)VIII proteins expressed from these 2 transcripts. FVIII is expressed in endothelial cells, primarily in the liver and lungs. Several studies have reported FVIII expression in other cell types, although this has been controversial. OBJECTIVES: To determine if partial FVIII proteins are expressed from intron 22-inverted and/or F8B mRNA and if FVIII is expressed in nonendothelial cells. METHODS: A panel of FVIII-specific antibodies was validated and employed to label FVIII in cells and tissues and for immunoprecipitation followed by western blots and mass spectrometry proteomics analysis. RESULTS: Immunofluorescent staining localized FVIII to endothelial cells in liver sections from non-HA but not HA-Int22Inv dogs. Neither FVIII nor FVIIIB was detected in human peripheral blood mononuclear cells, B cell or T cell lines, or cell lines expanded from peripheral blood mononuclear cells, whereas FVIII antigen and activity were readily detected in primary nonhemophilic liver sinusoidal endothelial cells. CONCLUSION: If FVIII is expressed in nonendothelial cells or if partial FVIII proteins are expressed in HA-Int22Inv, the concentrations are below the detection limits of these sensitive assays. Our results argue against promotion of immune tolerance through expression of partial FVIII proteins in Int-22Inv patients.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Vir P, Gunasekera D, Dorjbal B, et al. Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk. J Thromb Haemost. 2024. PMID: 39233012. doi:10.1016/j.jtha.2024.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。